---
created: 2025-04-13
updated: 2025-04-13T10:51
id: z?2YX,Hv>g
specialty: obgyn
specialty_id: 52
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::18-pulm::03-other::08-pulm-embolism
  - source/ak-step1-v11::
  - theme/firstaid::05-pharmacology::03-toxicities-&-side-effects::03-drug-reactions---endocrine/reproductive
  - source/ak-step1-v11::
  - theme/firstaid::15-repro::05-pharm::10-combined-contraception
  - source/ak-step1-v11::
  - source/ome-banner
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::12-reproductive::06-combined-contraception-and-copper-iuds
  - source/ak-step1-v11::
  - theme/sketchypharm::reproductive
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::reproductive::pharmacology
  - source/ak-step2-v11::
  - theme/b&b::06-obgyn::gyne::02-contraception"
type: flashcard
---

# Question
Combined contraceptives are contraindicated in patients with increased risk for **cardiovascular** disease

---

# Answer
e.g. history of DVT, coronary artery disease, or stroke  this is due to the estrogen portion of the contraceptive generating a hyper coagulable state